top of page
Search


Novel Function of MeCP2 Protein Could Be Route to Rett Therapy, Study Suggests
Mutations in the MECP2 gene, which lead to most cases of Rett syndrome, prevent the formation of droplet-like structures that regulate DNA.

Jonathan Shar
Jul 25, 20203 min read


1 in 5 Australians are struggling with mental health – what does this mean for ECEC?
A new report, released yesterday by the Australian Institute for Health and Welfare (AIHW) confirms how widespread mental illness...

Jonathan Shar
Jul 24, 20202 min read
Researchers develop a novel method for diagnosing Duchenne Muscular Dystrophy
Duchenne muscular dystrophy (DMD) is a rapidly progressive form of muscular dystrophy caused by a mutation in the DMD gene.

Jonathan Shar
Jul 24, 20204 min read


How to Deal Anxiety
I’ve known for a long time that I have anxiety.

Jonathan Shar
Jul 24, 20202 min read


Potential Sanfilippo Treatment, SLS-005, Advances as Orphan Drug in EU
The Committee for Orphan Medicinal Products, a branch of the European Medicines Agency (EMA).

Jonathan Shar
Jul 24, 20202 min read


Dylan Alcott tells Kurt Fearnley on One Plus One how sport opened doors, and maybe saved his life
Dylan Alcott says he doesn't know if he would "even be here at all" if it were not for the impact sport has had on his life.

Jonathan Shar
Jul 23, 20204 min read


Disability royal commission data shows Indigenous and culturally diverse groups under-represented
Dr Dinesh Palipana had struggled to maintain employment that was otherwise guaranteed to medical graduates because of a spinal cord injury.

Jonathan Shar
Jul 23, 20205 min read


Inflammatory Markers May Help Predict Exacerbations in Children with Cystic Fibrosis
Levels of inflammatory markers in the lungs may help predict pulmonary exacerbations in children with cystic fibrosis (CF).

Jonathan Shar
Jul 23, 20203 min read


Tofersen Safe, Appears to Slow Disease Progression in SOD1 ALS Patients, Phase 1/2 Trial Shows
Tofersen, Biogen’s investigational therapy for people with familial amyotrophic lateral sclerosis (ALS) caused by SOD1 gene mutations.

Jonathan Shar
Jul 23, 20205 min read


Beyond Blue encourages educators to put themselves first and guard mental health
Record numbers of early childhood education and care (ECEC) professionals, along with educators in other fields of education.

Jonathan Shar
Jul 22, 20202 min read


Tysabri Use Can Lessen Disability in RRMS Patients, Real-world Study Reports
Treatment with Tysabri (natalizumab) can lessen disability in people with relapsing-remitting multiple sclerosis (RRMS).

Jonathan Shar
Jul 22, 20203 min read


Chronic fatigue syndrome may hold keys to understanding post-Covid syndrome
Some survivors of acute bouts of Covid-19 experience a range of persistent medical issues — some lasting for weeks, or even months...

Jonathan Shar
Jul 22, 20204 min read


No, You Aren’t a ‘Savage’ for Being Unable to Return That Cart
About a year ago, my sister and I went to an arts and crafts store. Upon entering, I instinctively wanted to steer the shopping cart, and of

Jonathan Shar
Jul 22, 20202 min read


ALS scientific breakthrough: Diabetes drug metformin shows promise in mouse study for a common type
An FDA-approved diabetes drug shows early signs of promise against the most common genetic form of amyotrophic lateral sclerosis.

Jonathan Shar
Jul 22, 20200 min read


JobTrainer may have potential to boost disability workforce
The JobTrainer program aims to assist school leavers and job seekers with learning new skills in target areas identified by the National Sk

Jonathan Shar
Jul 21, 20202 min read


New Technology Offers Potential for Faster, More Accurate CF Diagnosis
New technology could enable faster and more accurate cystic fibrosis (CF) diagnoses by non-invasively tracking the movement of air through

Jonathan Shar
Jul 17, 20203 min read


Hansa Licenses Imlifidase to Sarepta as Gene Therapy Pre-treatment for DMD, LGMD
Hansa Biopharma has granted an exclusive worldwide license to Sarepta Therapeutics to develop and promote imlifidase as a gene therapy pre-

Jonathan Shar
Jul 16, 20202 min read


BRD4 Protein May be Therapeutic Target for Rett Syndrome, Study Suggests
By targeting a protein called BRD4, an experimental cancer treatment known as JQ1 reversed cellular abnormalities and extended survival in

Jonathan Shar
Jul 16, 20203 min read


Hansa Licenses Imlifidase to Sarepta as Gene Therapy Pre-treatment for DMD, LGMD
Hansa Biopharma has granted an exclusive worldwide license to Sarepta Therapeutics to develop and promote imlifidase as a gene therapy pre-

Jonathan Shar
Jul 15, 20202 min read
Drug for Rare Form of ALS Shows Promise
An experimental drug for a rare, inherited form of amyotrophic lateral sclerosis (ALS) has shown promise in phase 1/2 clinical trials, ...

Jonathan Shar
Jul 14, 20202 min read
bottom of page








